K. L. Blackwell - Concepedia

Author

K. L. Blackwell

Also Known As

K Blackwell, K L Blackwell, K. Blackwell, K. L. Blackwell, K.L. Blackwell, Kenneth Blackwell, KimberlyL Blackwell

Publications

560

Citations

H-Index

Concepts

All Affiliations

K. L. Blackwell is an author at Duke Medical Center specializing in breast cancer, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	325
2	Pathology	2	2	238
3	Health Sciences	1	1	157
4	Endocrinology	1	1	81
5	Immunology	1	1	157

K. L. Blackwell

Publications

432

Citations

H-Index

Page 1

	Year	Citations
A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy J. O’Shaughnessy, K. L. Blackwell, Harold J. Burstein, Journal of Clinical Oncology Breast OncologyImmunologyPathologyPharmacotherapyOncology	2008	157
Neratinib in combination with trastuzumab for the treatment of advanced breast cancer: A phase I/II study Ramona F. Swaby, K. L. Blackwell, Zefei Jiang, Journal of Clinical Oncology Advanced Breast CancerPart 1OncologyBreast OncologyPhase I/ii Study	2009	87
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. K. L. Blackwell, Zishan A. Haroon, Saijun Shan, PubMed AngiogenesisMedicineTumor GrowthHormonal ReceptorEstrogen Receptor	2000	81
Reconstruction of the Laryngopharynx After Hemicricoid/Hemithyroid Cartilage Resection: Preliminary Functional Results Mark L. Urken, K. L. Blackwell, Hugh F. Biller Archives of Otolaryngology - Head and Neck Surgery	1997	56
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification Zahid N. Rabbani, Matthew E. Hardee, S J Kim, British Journal of Cancer	2012	51

Page 1